Jason Cantor
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jason Cantor
Jason Cantor has spoken on 1 investor event across 1 company, most recently for Nurix Therapeutics, Inc. on September 8, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Nurix Therapeutics, Inc. (NRIX)
Transcript header (unverified)
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Nurix Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Arthur T. Sands CEO, Board Member
- Hans van Houte CFO
- Stefani Wolff COO
- Christine Ring General Counsel
- Anil Kapur Board Member
- Clay B. Siegall, Ph.D. Board Member
- Edward C. Saltzman Board Member
- Judith A. Reinsdorf Board Member
- Paul M. Silva Board Member
- Roger Dansey, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.